Seven Bridges Genomics funds open access to bioinformatics research
We want to do everything possible to accelerate the pace of discovery, said Deniz Kural, Seven Bridges Genomics’ CEO.
Open is the next step of what we started with Rabix — our open-source toolkit for creating, running, and sharing bioinformatics workflows. We want to disseminate knowledge faster, and pairing open access research with fully portable workflows is the best way we know to do it.
For more information about Open, and to submit your fee information, visit www.sbgenomics.com/open/
For more information about Rabix, and to try a workflow, visit www.rabix.org/
About Seven Bridges Genomics Inc.
Seven Bridges Genomics is the cloud-powered platform for population-scale bioinformatics. Researchers use it to carry out investigations by interactively working with data. They also automate analyses on the platform to generate answers reproducibly and at scale. Scientists benefit from its speed and compliance with HIPAA, EU data protection directives and the U.S. Safe Harbor agreement. Seven Bridges is the choice of biotechnology and pharmaceutical companies and national governments. It is the only bioinformatics software company to operate at national scale on both sides of the Atlantic, serving both the US and UK governments.